CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome
Test Details
The CNTNAP2 gene is associated with a rare genetic disorder called Cortical dysplasia-focal epilepsy syndrome (CDFE). This disorder is characterized by abnormal brain development, which leads to seizures and other neurological symptoms.
NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze a person’s DNA. This technology allows for the simultaneous analysis of multiple genes, making it an efficient and effective way to diagnose genetic disorders like CDFE. The CNTNAP2 gene is one of many genes that may be analyzed using NGS genetic testing to diagnose CDFE. By identifying mutations or variations in this gene, healthcare providers can make a more accurate diagnosis and develop a personalized treatment plan for individuals with CDFE.
Test Name | CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome |
Test Details | The CNTNAP2 gene is associated with a rare genetic disorder called Cortical dysplasia-focal epilepsy syndrome (CDFE). This disorder is characterized by abnormal brain development, which leads to seizures and other neurological symptoms. NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze a person’s DNA. This technology allows for the simultaneous analysis of multiple genes, making it an efficient and effective way to diagnose genetic disorders like CDFE. The CNTNAP2 gene is one of many genes that may be analyzed using NGS genetic testing to diagnose CDFE. By identifying mutations or variations in this gene, healthcare providers can make a more accurate diagnosis and develop a personalized treatment plan for individuals with CDFE. |